OCALIVA Trademark

Trademark Overview

On Friday, July 31, 2015, a trademark application was filed for OCALIVA with the United States Patent and Trademark Office. The USPTO has given the OCALIVA trademark a serial number of 86710865. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, October 8, 2022. This trademark is owned by RXF Technologies, Inc.. The OCALIVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of chronic liver diseases
ocaliva

General Information

Serial Number86710865
Word MarkOCALIVA
Filing DateFriday, July 31, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, October 8, 2022
Registration Number5014396
Registration DateTuesday, August 2, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of chronic liver diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 5, 2015
Primary Code005
First Use Anywhere DateThursday, April 14, 2016
First Use In Commerce DateTuesday, May 31, 2016

Trademark Owner History

Party NameINTERCEPT PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameINTERCEPT PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10011
Party NameRXF Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRoyal Oak, MI 48067
Party NameRXF Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRoyal Oak, MI 48067

Trademark Events

Event DateEvent Description
Saturday, October 8, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, October 8, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, October 8, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 11, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, August 2, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, September 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 2, 2016REGISTERED-PRINCIPAL REGISTER
Friday, July 1, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 30, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 23, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 31, 2016USE AMENDMENT FILED
Thursday, June 23, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 15, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 31, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, May 31, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 16, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 16, 2015NON-FINAL ACTION E-MAILED
Monday, November 16, 2015NON-FINAL ACTION WRITTEN
Thursday, November 12, 2015ASSIGNED TO EXAMINER
Wednesday, August 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 4, 2015NEW APPLICATION ENTERED

Related Keywords

ocaliva liver diseases chronic treatment preparations human pharmaceutical